FI924019A - Förfarande för producering av ett vattenhaltigt suspensionspreparat - Google Patents

Förfarande för producering av ett vattenhaltigt suspensionspreparat Download PDF

Info

Publication number
FI924019A
FI924019A FI924019A FI924019A FI924019A FI 924019 A FI924019 A FI 924019A FI 924019 A FI924019 A FI 924019A FI 924019 A FI924019 A FI 924019A FI 924019 A FI924019 A FI 924019A
Authority
FI
Finland
Prior art keywords
preparation
less
producing
aqueous suspension
diameter
Prior art date
Application number
FI924019A
Other languages
English (en)
Finnish (fi)
Other versions
FI98890B (sv
FI924019A0 (sv
FI98890C (sv
Inventor
Eric Willem Ackerman
Rene Jacobus Elisabert Grouls
Hendrikus Hubertus Mar Korsten
Original Assignee
Ziekenhuis Stichting Catharina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ziekenhuis Stichting Catharina filed Critical Ziekenhuis Stichting Catharina
Publication of FI924019A0 publication Critical patent/FI924019A0/sv
Publication of FI924019A publication Critical patent/FI924019A/sv
Publication of FI98890B publication Critical patent/FI98890B/sv
Application granted granted Critical
Publication of FI98890C publication Critical patent/FI98890C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI924019A 1990-03-20 1992-09-08 Förfarande för producering av ett vattenhaltigt suspensionspreparat FI98890C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL9000634 1990-03-20
NL9000634A NL9000634A (nl) 1990-03-20 1990-03-20 Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
PCT/NL1991/000042 WO1991014455A1 (en) 1990-03-20 1991-03-20 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief
NL9100042 1991-03-20

Publications (4)

Publication Number Publication Date
FI924019A0 FI924019A0 (sv) 1992-09-08
FI924019A true FI924019A (sv) 1992-09-08
FI98890B FI98890B (sv) 1997-05-30
FI98890C FI98890C (sv) 1997-09-10

Family

ID=19856770

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924019A FI98890C (sv) 1990-03-20 1992-09-08 Förfarande för producering av ett vattenhaltigt suspensionspreparat

Country Status (15)

Country Link
US (1) US5346903A (sv)
EP (1) EP0521070B1 (sv)
JP (1) JPH05507466A (sv)
AT (1) ATE121631T1 (sv)
AU (1) AU646857B2 (sv)
BR (1) BR1100601A (sv)
CA (1) CA2077641C (sv)
DE (1) DE69109279T2 (sv)
DK (1) DK0521070T3 (sv)
ES (1) ES2074269T3 (sv)
FI (1) FI98890C (sv)
GR (1) GR3015940T3 (sv)
NL (1) NL9000634A (sv)
NO (1) NO300114B1 (sv)
WO (1) WO1991014455A1 (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206267A (en) * 1991-05-09 1993-04-27 Morton Shulman Pain controlling composition and method of preparation
US5635540A (en) * 1994-12-09 1997-06-03 The University Of Virginia Patent Foundation Stabilized topical pharmaceutical preparations
US6077545A (en) 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
ES2341399T3 (es) * 1996-03-26 2010-06-18 Eli Lilly And Company Benziotofenos, formulaciones que contienen los mismos y procedimientos.
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
JP2004527573A (ja) * 2001-04-24 2004-09-09 パーデュー・リサーチ・ファウンデーション 哺乳類の神経組織損傷の治療のための方法及び組成物
AU2003211009A1 (en) * 2002-02-11 2003-09-04 Wake Forest University Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
US7838034B2 (en) 2002-07-30 2010-11-23 Grunenthal Gmbh Intravenous pharmaceutical form of administration
DE10234784A1 (de) * 2002-07-30 2004-02-19 Günenthal GmbH Intravenös applizierbare, pharmazeutische Darreichungsform
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
JP4686361B2 (ja) * 2002-12-31 2011-05-25 アルタス ファーマシューティカルズ インコーポレイテッド ヒト成長ホルモンの結晶およびその調製方法
WO2004060920A1 (en) * 2002-12-31 2004-07-22 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
WO2007076131A2 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
JP2010513309A (ja) * 2006-12-18 2010-04-30 アルタス ファーマシューティカルズ インコーポレイテッド ヒト成長ホルモン製剤
FI20075091A0 (sv) * 2007-02-09 2007-02-09 Kim Lemberg Noroximorfon för användning som läkemedel
US20080227805A1 (en) * 2007-02-28 2008-09-18 Abbott Laboratories Sustained release parenteral formulations of buprenorphine
US9125867B2 (en) * 2010-02-24 2015-09-08 Invincible Biotechnology Diversion- and/or abuse-resistant compositions and methods for making the same
GB2513060B (en) * 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
AU2015341490C1 (en) 2014-11-07 2021-03-11 Indivior Uk Limited Buprenorphine dosing regimens
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
WO2022175977A1 (en) * 2021-02-18 2022-08-25 Navin Saxena Research And Technology Private Limited A biodegradable implant composition and process for long term delivery of buprenorphine and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB784659A (en) * 1954-11-26 1957-10-16 Upjohn Co Therapeutic compositions and aqueous suspensions thereof
US3337406A (en) * 1963-12-12 1967-08-22 Mar Sal Inc Treatment of arteriosclerotic diseases
EP0031603A1 (en) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmaceutical composition of matter
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4599354A (en) * 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief

Also Published As

Publication number Publication date
BR1100601A (pt) 2000-04-18
NO300114B1 (no) 1997-04-14
NO923429L (no) 1992-09-17
CA2077641C (en) 2001-07-03
JPH05507466A (ja) 1993-10-28
AU646857B2 (en) 1994-03-10
FI98890B (sv) 1997-05-30
EP0521070B1 (en) 1995-04-26
CA2077641A1 (en) 1991-09-21
WO1991014455A1 (en) 1991-10-03
FI924019A0 (sv) 1992-09-08
DE69109279D1 (de) 1995-06-01
ATE121631T1 (de) 1995-05-15
AU7558091A (en) 1991-10-21
NL9000634A (nl) 1991-10-16
GR3015940T3 (en) 1995-07-31
US5346903A (en) 1994-09-13
EP0521070A1 (en) 1993-01-07
NO923429D0 (no) 1992-09-03
FI98890C (sv) 1997-09-10
DE69109279T2 (de) 1995-11-09
DK0521070T3 (da) 1995-05-22
ES2074269T3 (es) 1995-09-01

Similar Documents

Publication Publication Date Title
FI98890B (sv) Förfarande för producering av ett vattenhaltigt suspensionspreparat
IL115878A0 (en) Small particle formation
DK0577215T3 (da) Fremgangsmåde til fremstilling af overflademodificerede anticancer-nanopartikler
ZA929161B (en) Microcrystalline cellulose spheronization composition.
MY110186A (en) The use of tyloxapol as a nanoparticle stabilizer and dispersant.
NO971792D0 (no) Blanding inneholdende en aerogel, dens fremstilling og anvendelse
ATE150310T1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
KR900007319A (ko) 살충 조성물
JPS5799521A (en) Solid composition containing bisacodyl
EP0048944A1 (en) An antimicrobial preparation
EP0135189A3 (en) Pharmaceutically useful malonamides
ES8506338A1 (es) Procedimiento de intensificar cultivos agricolas y similares
CA1038761A (en) Composition for controlling sexual behavior of mammals
JPS57197220A (en) Muscle relaxant
TH10154EX (th) 4-เฟนิล-4 ไพเพอริดีนคาร์บอกแซมีด ที่ถูก-แทนที่ที่มีผลทั้งผลทั้งเป็นยาชาเฉพาะที่และยาระงับปวดและกรรมวิธีการเตรียม
Guilloteau et al. MIBG and catecholamine storage in the brain: an in-vitro study
Parellada et al. Local anaesthetics imidazole and calcium
Peterson et al. Acute inhibition of microsomal drug metabolism by propoxyphene in narcotic tolerant/dependent mice
AU5975290A (en) Liquid suspensions of nitrofurantoin
JPS57154130A (en) Pharmaceutical composition having uterotonic activity
KR890014115A (ko) 4-(3-포스포노-2-프로페닐)-2-피페라진카르복실산의 신규한 용도
JPH01207231A (ja) 肝類洞小孔拡張・増加剤

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired